SPONSOR
Central Hospital, Nancy, France
Total Trials
5
Recruiting
5
Phases
N/A
Conditions studied: Hepatocellular Carcinoma (HCC)CirrhosisRisk Prediction for Liver CancerEpigenomicsEvent Suggestive of Multiple SclerosisMultiple SclerosisAcute Heart FailureLiver NeoplasmHeart Failure
Central Hospital, Nancy, France is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma (HCC), Cirrhosis, Risk Prediction for Liver Cancer, Epigenomics.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Central Hospital, Nancy, France
How many clinical trials has Central Hospital, Nancy, France sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Central Hospital, Nancy, France, of which 5 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma (HCC), Cirrhosis, Risk Prediction for Liver Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Central Hospital, Nancy, France research focus on?
Central Hospital, Nancy, France clinical trials span Hepatocellular Carcinoma (HCC), Cirrhosis, Risk Prediction for Liver Cancer, Epigenomics, Event Suggestive of Multiple Sclerosis, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Central Hospital, Nancy, France clinical trial?
To participate in a Central Hospital, Nancy, France trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Central Hospital, Nancy, France trials with current recruitment status updated daily.
Clinical Trials by Central Hospital, Nancy, France
NCT06778317
Recruiting
mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
Hepatocellular Carcinoma (HCC)
NCT07492667
Recruiting
Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life
Event Suggestive of Multiple Sclerosis
NCT04343430
Recruiting
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation
Acute Heart Failure
NCT07413640
Recruiting
Variability of Microwave Ablation Volume Based on Clinical, Radiological, Biological, and Tissue Factors
Liver Neoplasm
NCT04741711
Recruiting
AMBulatory UltraSound for Heart Failure Management
Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology